Skip to main content

GO Krill Oil 1,500 mg 1-A-Day Odourless, The Better Health Company (Australia) PTY, CON-260

Product name
GO Krill Oil 1,500 mg 1-A-Day Odourless
Sponsor name
The Better Health Company (Australia) PTY
Consent start
Consent no.
CON-260
Standard
The United States Pharmacopeia-National Formulary (USP41-NF36) monograph for Krill Oil, the default standard for Krill Oil in Australia.
Non-compliance with standard
The content of palmitoleic acid exceeds the upper specification level by 0.16%. (Current USP41-NF36 specifications for palmitoleic acid are 2.5% to 9.0%).
Conditions imposed
    1. The content of palmitoleic to be within the specifications of  2.5% to 12.0%.     2. The raw material in relation to which the consent is given must comply with all other applicable parts of the USP41-NF36 and all other applicable standards.      
Therapeutic product type
Listed complementary medicines

Help us improve the Therapeutic Goods Administration site